NM_014164.6:c.134G>C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_014164.6(FXYD5):​c.134G>C​(p.Arg45Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000363 in 1,377,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R45Q) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000036 ( 0 hom. )

Consequence

FXYD5
NM_014164.6 missense

Scores

18

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0930

Publications

0 publications found
Variant links:
Genes affected
FXYD5 (HGNC:4029): (FXYD domain containing ion transport regulator 5) This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. This gene product, FXYD5, is a glycoprotein that functions in the up-regulation of chemokine production, and it is involved in the reduction of cell adhesion via its ability to down-regulate E-cadherin. It also promotes metastasis, and has been linked to a variety of cancers. Alternative splicing results in multiple transcript variants. [RefSeq curation by Kathleen J. Sweadner, Ph.D., sweadner@helix.mgh.harvard.edu., Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.022924274).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014164.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FXYD5
NM_014164.6
MANE Select
c.134G>Cp.Arg45Pro
missense
Exon 3 of 9NP_054883.3
FXYD5
NM_001320912.2
c.134G>Cp.Arg45Pro
missense
Exon 3 of 9NP_001307841.1F5H4X8
FXYD5
NM_001164605.2
c.134G>Cp.Arg45Pro
missense
Exon 3 of 9NP_001158077.1Q96DB9-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FXYD5
ENST00000392219.7
TSL:1 MANE Select
c.134G>Cp.Arg45Pro
missense
Exon 3 of 9ENSP00000376053.2Q96DB9-1
FXYD5
ENST00000342879.7
TSL:1
c.134G>Cp.Arg45Pro
missense
Exon 2 of 8ENSP00000344254.3Q96DB9-1
FXYD5
ENST00000718431.1
c.134G>Cp.Arg45Pro
missense
Exon 3 of 10ENSP00000520816.1A0ABB0MVH5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000363
AC:
5
AN:
1377676
Hom.:
0
Cov.:
21
AF XY:
0.00000580
AC XY:
4
AN XY:
690068
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31750
American (AMR)
AF:
0.00
AC:
0
AN:
44622
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25570
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38972
South Asian (SAS)
AF:
0.0000593
AC:
5
AN:
84386
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53268
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5610
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1035952
Other (OTH)
AF:
0.00
AC:
0
AN:
57546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.68
DANN
Benign
0.60
DEOGEN2
Benign
0.0033
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0059
N
LIST_S2
Benign
0.42
T
M_CAP
Benign
0.0079
T
MetaRNN
Benign
0.023
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
-1.6
N
PhyloP100
-0.093
PrimateAI
Benign
0.22
T
PROVEAN
Benign
3.5
N
REVEL
Benign
0.048
Sift
Benign
0.27
T
Sift4G
Benign
0.28
T
Polyphen
0.0
B
Vest4
0.091
MutPred
0.33
Gain of sheet (P = 0.0477)
MVP
0.35
MPC
0.17
ClinPred
0.11
T
GERP RS
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.062
gMVP
0.047
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140956604; hg19: chr19-35648396; API